Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.
Smoking can be a cause of heart disease, so we investigated the impact of NGP aerosols on immune and endothelial cells, in-vitro.
20 Jun 2024
In part 2, Thomas Nahde focuses on the challenges industry faces when it comes to communication around nicotine – and suggests some solutions.
16 May 2024
Imperial Brands is dedicated to safeguarding our consumers; this infographic explains what we do, how we do it, and why it’s important.
15 May 2024
In the first of a two-part series, Thomas Nahde discusses the reputational, societal, and regulatory challenges facing nicotine.
13 May 2024
We believe tobacco-free oral nicotine pouches can help make a meaningful contribution to tobacco harm reduction. Our literature review demonstrates why.
18 Apr 2024
To explain more about our consumer-centric approach to potentially harm reduced next generation products, we’ve created a new science and innovation brochure – Beyond Smoke.
8 Apr 2024
